Sinoway Industrial Co., Ltd.

Aripiprazole Intermediates 129722-34-5 Aripiprazole Intermediates 129722-34-5

Aripiprazole Intermediates 129722-34-5
Related Products
  • L-Glutathione Reduced (GSH) 70-18-8

    L-Glutathione ReducedBasic information of L-Glutathione Reduced:Product name: L-Glutathione ReducedMolecular Formula : C20H32N6O12S2Molecular Weight: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc...

  • Copper Peptide (GHK)2-CU 49557-75-7

    Copper peptide GHK-CuBasic information of copper peptide GHK-Cu :Product Name(GHK)2-Cu(Copper Peptide)SynonymsGHK-Cu (Copper peptide)CAS #49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2...

  • Isoflavones in Soy 574-12-9

    Soybean Extract1.Basic information of Soybean Extract:Product name: Soybean ExtractSource: glycine maxUsed part: germ/bean pulpSpec.: total soy isoflavone 40%, 80% by HPLCNameSoybean Extract PowderTyp...

Basic Information of Aripiprazole Intermediates 129722-34-5

  • CAS No. of intermediates: 129722-34-5
  • Other Names: 7-(4-Bromobutoxy)-3,4-dihydro-2(1H)-quinolinone
  • MF: C13H16BrNO2
  • MW: 298.18
  • Melting point: 110-111°C
  • Purity: 99.0%min
  • Application: Pharm Intermediates
  • Appearance: White crystalline powder, White crystalline powder
  • Item:129722-34-5 & other Aripiprazole intermediates
  • Shelf life: 2 years

Usage of Aripiprazole Intermediates 129722-34-5

  • Aripiprazole tablets, indications for the treatment of schizophrenia. Short-term (4-week and 6-week) controlled trials of schizophrenics established the efficacy of aripiprazole in the treatment of schizophrenia. Physicians who choose aripiprazole for long-term treatment should periodically re-evaluate the drug's long-term efficacy in individual patients.
  • Compared with placebo, the use of atypical antipsychotics for Alzheimer's related psychosis increases the risk of death. Seventeen placebo-controlled studies of similar drugs found that the mortality rate in the drug-treated group was 1.6 to 1.7 times that in the placebo group. The mortality rate for the drug-treated group in a typical 10-week placebo-controlled trial was 4.5% compared to the 2.6% mortality in the placebo group. Although the cause of death varies, most seem to be associated with cardiovascular disease (such as heart failure or sudden death) or infection (such as pneumonia). Aripiprazole can not be used for the treatment of dementia-related psychosis.

MORE_DETAIL Aripiprazole Intermediates 129722-34-5

Basic Information of Aripiprazole Intermediates 129722-34-5

  • CAS No. of intermediates: 129722-34-5
  • Other Names: 7-(4-Bromobutoxy)-3,4-dihydro-2(1H)-quinolinone
  • MF: C13H16BrNO2
  • MW: 298.18
  • Melting point: 110-111°C
  • Purity: 99.0%min
  • Application: Pharm Intermediates
  • Appearance: White crystalline powder, White crystalline powder
  • Item:129722-34-5 & other Aripiprazole intermediates
  • Shelf life: 2 years

Usage of Aripiprazole Intermediates 129722-34-5

  • Aripiprazole tablets, indications for the treatment of schizophrenia. Short-term (4-week and 6-week) controlled trials of schizophrenics established the efficacy of aripiprazole in the treatment of schizophrenia. Physicians who choose aripiprazole for long-term treatment should periodically re-evaluate the drug's long-term efficacy in individual patients.
  • Compared with placebo, the use of atypical antipsychotics for Alzheimer's related psychosis increases the risk of death. Seventeen placebo-controlled studies of similar drugs found that the mortality rate in the drug-treated group was 1.6 to 1.7 times that in the placebo group. The mortality rate for the drug-treated group in a typical 10-week placebo-controlled trial was 4.5% compared to the 2.6% mortality in the placebo group. Although the cause of death varies, most seem to be associated with cardiovascular disease (such as heart failure or sudden death) or infection (such as pneumonia). Aripiprazole can not be used for the treatment of dementia-related psychosis.
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//